A panel of medtech investors convened today for DeviceTalks Boston included David Neustaedter, vice president of venture capital at Medtronic (NYSE: MDT). He’s spent 14 years in the role, including as director of venture capital at Covidien before Medtronic acquired the company (read more in his DeviceTalks speaker bio). Medtronic has more than $500 million in […]
DeviceTalks Boston
Here’s where Harvard’s engineering dean sees medtech research going
Surgical robotics, artificial intelligence, and combatting climate change are but some of the priorities that have Harvard’s engineering school dean excited. Speaking today at DeviceTalks Boston, Frank J. Doyle III described the Harvard John A. Paulson School of Engineering and Applied Sciences as a “well-kept secret” historically. But Harvard engineering is staking out a strong […]
Meet a wide range of medical device suppliers at DeviceTalks Boston
DeviceTalks Boston is shaping up to be a great chance not only to hear from top medtech leaders and network with more than 700 industry insiders — but also to meet the dozens of medical device industry suppliers exhibiting on the show floor. Exhibitors at the Boston Convention and Exhibitor Center — May 10–11, 2022 — include contract […]
DeviceTalks Boston hosting MedTech Innovator mid-stage pitch competitions on May 10-11
Twenty-five mid-stage medical device startups will pitch their exciting medtech stories at DeviceTalks Boston on May 10-11 at the Boston Convention & Exhibition Center as part of the MedTech Innovator Mid-Stage Companies Pitch Event. The pitch event is thanks to a new partnership between DeviceTalks, organizer of a portfolio of events and podcasts serving the […]
How Stryker is advancing digital healthcare
Count Stryker among the big medical device companies that have pioneered the transition toward digital, becoming medtech companies offering an array of software and services around their products. The company’s popular Mako robotic surgery systems are more than just the robot when it comes to knee and hip surgeries. There’s the preoperative data modeling and […]
How Johnson & Johnson’s DePuy Synthes is shifting toward digital
Johnson & Johnson is increasingly digitizing in the medical device space, with the company even recently rebranding the business to Johnson & Johnson MedTech to reflect the shift. Many medtech companies have embraced the trend. It’s all about providing software, knowledge and insights to boost healthcare outcomes and hopefully help the system operate more efficiently […]
How Insulet created its next-gen Omnipod 5
Insulet (NSDQ:PODD) added to its portfolio of life-changing diabetes management technologies when its Omnipod 5 received FDA clearance in January. Omnipod 5 provides easier glucose management, with no multiple daily injections, no tubes and zero fingersticks. Paired with Dexcom’s G6 continuous glucose monitoring (CGM) system, Omnipod 5 is the first tubeless, wearable, automated insulin delivery […]
Where are LVADs headed in the future?
Abbott (NYSE:ABT) became the dominant provider of left ventricular assist devices (LVADs) after Medtronic’s decision last year to leave the market. The Abbott HeartMate 3‘s advantages include its Full MagLev flow technology — which involves a free-floating magnetically levitated rotor that prevents surface-to-surface contact that could cause blood trauma. In addition, system batteries provide up […]
How medtech is tackling supply chain challenges
Join us at DeviceTalks Boston on May 10-11 to hear how medical device companies are propping open supply lines and ensuring a steady flow of products to customers in a constantly changing world. Sharing best practices is more important than ever because supply chain challenges aren’t expected to diminish post-pandemic. That’s because superstorms, fires, droughts and other extreme […]
What is the future of cardiac ablation?
Pulsed-field ablation (PFA) — a non-thermal method for cardiac ablation — has the potential to positively disrupt the atrial fibrillation market. Amid the excitement around the technology, Medtronic announced in January that it would acquire cardiac mapping and ablation technology developer Affera for nearly $1 billion. Meanwhile, Boston Scientific in February closed its $1.75 billion […]
Discover where this artificial pancreas pioneer sees medtech development going
Frank Doyle — a prolific medical device inventor and Harvard engineering school leader — will discuss the future of medtech development during DeviceTalks Boston, May 10–11, 2022. A pioneer in developing artificial pancreas technology to treat diabetes, Doyle will share his insights on the future of medical device development, including the expanding role of robotics […]